Engineering exosome-based gene therapies: Tools, targets, and AI-enabled genomic design
Journal of Applied Biology & Biotechnology · 2026
DOI: 10.7324/jabb.2026.283092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Biology & Biotechnology, 2026. Verfasst von Ali Abuhaliema und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 3.0).
Abstract (Originalsprache)
Exosomes, a category of extracellular vesicles (EVs), are being engineered as biocompatible nanocarriers for gene and genome-editing agents, such as messenger RNA, small interfering RNA/antisense oligonucleotides, plasmid DNA, and CRISPR/Cas (clustered regularly interspaced short palindromic repeats / CRISPR-associated) systems. Their intrinsic membrane composition can safeguard sensitive cargos, diminish immunogenicity, and enable repeated administration; nevertheless, translation is hindered by inconsistent isolation and characterization, variable cargo loading, non-specific biodistribution, and challenges in manufacturing scale-up. This review consolidates recent advancements in the engineering of exosomes for therapeutic gene delivery and introduces an integrated AI-enabled design framework. This framework utilizes AI-assisted whole-exome sequencing variant prioritization to guide target selection, modality determination, and exosome engineering choices, including loading strategies, surface targeting, and mechanism-linked potency assessments. We detail novel exosome-mediated CRISPR delivery methods, critically evaluate safety concerns and potential failure modes, and delineate a pragmatic translational roadmap consistent with expectations for EV standardization. The integration of patient genetics with vector design and manufacturing quality characteristics through AI-exosome convergence provides a pathway to more systematic, reproducible, and clinically scalable gene treatments.
Zitieren
APA
Abuhaliema, A., Al-Samydai, A., Mahmood, T. H., Ahmed, R. M., Al-Sammarraie, T. R., & Agha, A. S. A. (2026). Engineering exosome-based gene therapies: Tools, targets, and AI-enabled genomic design. Journal of Applied Biology & Biotechnology. https://doi.org/10.7324/jabb.2026.283092
Vancouver
Abuhaliema A, Al-Samydai A, Mahmood TH, Ahmed RM, Al-Sammarraie TR, Agha ASA. Engineering exosome-based gene therapies: Tools, targets, and AI-enabled genomic design. Journal of Applied Biology & Biotechnology. 2026. doi:10.7324/jabb.2026.283092
BibTeX
@article{Abuhaliema2026,
author = {Abuhaliema, Ali and Al-Samydai, Ali and Mahmood, Tabarek H. and Ahmed, Ruqaya Mohammad and Al-Sammarraie, Tabarak R. and Agha, Ahmed S.A. Ali},
title = {Engineering exosome-based gene therapies: Tools, targets, and AI-enabled genomic design},
journal = {Journal of Applied Biology & Biotechnology},
year = {2026},
doi = {10.7324/jabb.2026.283092}
}
EUVIMED